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Abstract
Background: Autophagy is an evolutionarily conserved protein degradation pathway. A defect in autophagy may
contribute to tumorigenesis. Autophagy inducers could have a potential function in tumor prevention and treatment.
Methodology/Principal Findings: Our results showed that Rhabdastrellic acid-A, an isomalabaricane triterpenoid isolated
from the sponge Rhabdastrella globostellata, inhibited proliferation of human cancer cell lines Hep3B and A549 and
induced caspase-independent cell death in both the cell lines. Further investigation showed that Rhabdastrellic acid-A
induced autophagy of cancer cells determined by YFP-LC3 punctation and increased LC3-II. The pretreatment with
autophagy inhibitor 3-MA inhibited Rhabdastrellic acid-A-induced cell death. Knockdown of autophagy-related gene Atg5
inhibited Rhabdastrellic acid-A-induced cell death in A549 cells. Also, phospho-Akt and its downstream targets significantly
decreased after treatment with Rhabdastrellic acid-A in both cancer cell lines. Transfection of constitutive active Akt plasmid
abrogated autophagy and cell death induced by Rhabdastrellic acid-A.
Conclusions/Significance: These results suggest that Rhabdastrellic acid-A could induce autophagy-associated cell death
through blocking Akt pathway in cancer cells. It also provides the evidence that Rhabdastrellic acid-A deserves further
investigation as a potential anticancer or cancer preventive agent.
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Introduction
Marine sponges have been proven to be a particularly fruitful
source of unusual terpenoids[1,2]. Rhabdastrellic acid-A (Fig. 1),
an isomalabaricane triterpenoid, was isolated from the yellow
sponge Rhabdastrella globostellata (Carter) collected from the
South China Sea near Hainan Island, People’s Republic of China.
Its structure was established on the basis of UV, IR, MS,
1H-
NMR,
13C-NMR, and 2D NMR spectrometry [3,4]. The relative
and absolute stereochemistries were solved by NOESY and CD
studies, respectively. It has been reported that Rhabdastrellic acid-
A can inhibit growth of cancer cell line HCT-116. Tasdemir et al.
found that stellettin B and E, two terpenoids from Rhabdastrella
globostellata with structure similar to Rhabdastrellic acid-A,
preferentially inhibit p212/2 HCT-116 cell growth [5]. Other
isomalabaricane triterpenoids were found to induce reactive
oxygen species (ROS), decrease mitochondrial membrane poten-
tial, increase the levels of Bax and cytochrome c, decrease the
levels of Bcl-2 and mediate a caspases-3 apoptotic pathway, but
the molecular mechanisms responsible for triterpenoids-induced
cell death have not been elucidated yet[5]. Also, our investigation
showed that Rhabdastrellic acid-A induced apoptosis in HL-60
cells [4], but the development of apoptotic features in Hep3B and
A549 cells following exposure to Rhabdastrellic acid-A was not
observed.
Autophagy is a lysosomal degradation pathway that is essential
for survival, development, and homeostasis[6]. Autophagy princi-
pally serves an adaptive role to protect organisms against diverse
pathologies, including infections, cancer[7], neurodegeneration[8],
aging, and heart disease. Autophagic cell death has morphologic
and biochemical features distinguishing it from both apoptosis and
necrosis. At the early stage of tumour development, autophagy
functions as a tumor suppressor
39. Defects in autophagy lead to
genomic instability and tumorigenesis. However, the tumor cells
that are located in the central area of the tumor mass undergo
autophagy to survive under low-oxygen and low-nutrient condi-
tions. It was reported that autophagy protected some cancer cells
against anticancer treatments by blocking the apoptotic pathway.
By contrast, other cancer cells could undergo autophagic cell
death following cancer therapies [9].
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stress has been examined by interferencing the expression of
mammalian orthologues of the ATG gene [10]. For example,
Beclin 1 (BECN1; also known as Atg6) is one component of a
complex including the class III phosphotidylinositol-3-kinase that
is stimulatory for autophagy. Beclin 1 (ATG6) is also known to
interact with Bcl-2 family members, Bcl-2 and Bcl-xL[11,12]. The
induction of Beclin 1 expression can be found during autophagy in
various cell types[13]; and ATG5 is required for autophagy but
can also induce cell death via its interaction with Fas associated
protein through death domain[14]; Therefore, the results of these
important experiments may not at the moment be taken as a final
evidence for the role of autophagy as either a perpetrator or a
damage-ameliorating agent during stress, but more as a demon-
stration of the important roles its regulators are playing in cellular
homeostasis and tumorigenesis[15].
A number of signaling pathways are involved in regulation of
autophagy. One of the central regulators of autophagy is the target
of rapamycin, TOR kinase, which is the major inhibitory signal
that suppresses autophagy in the presence of growth factors and
abundant nutrients. The class I PI3K/Akt signaling molecules link
receptor tyrosine kinases to TOR activation and thereby repress
autophagy in response to insulin-like and other growth factor
signals[16]. Some of the other regulatory molecules that control
autophagy include 59-AMP-activated protein kinase (AMPK),
which responds to low energy; the eukaryotic initiation factor 2a
(eIF2a), which responds to nutrient starvation, double-stranded
RNA, and endoplasmic reticulum (ER) stress[17,18]. The
suppression of autophagic cell death by caspase-8 in mammalian
cells indicated that caspases can regulate both apoptotic and non-
apoptotic cell death[19].
For the past several decades, researchers have focused on the
central role of Akt in many human cancers[20,21,22,23,24,25].
Akt signaling pathway has emerged as a central route for
regulating multiple cellular processes, including survival and
proliferation of many cell types. To date, many human cancers
show hyperactivation of Akt kinases, thereby inhibition of Akt
pathway is considered as a promising strategy for cancer
treatment[26,27,28,29,30,31,32].
In the present study, we explored that the possibility that
Rhabdastrellic acid-A killed human cancer cells via the induction
of autophagy. We found that Hep3B and A549 cells treated with
Rhabdastrellic acid-A underwent morphologic and biochemical
changes consistent with the induction of autophagy and cell death.
The mechanism of autophagy induction by Rhabdastrellic acid-A
is associated with inhibition of Akt pathway.
Results
1. Rhabdastrellic acid-A induced caspase-independent
cell death in Hep3B and A549 cells
The treatment of Hep3B and A549 cells for 3 d with various
concentrations of Rhabdastrellic acid-A resulted in inhibition of cell
growth in a dose-dependent manner. IC50 value was 0.42 mg/mL
and 2.50 mg/mL (Fig. 2A). Inhibition of cell growth could be the
results of the induction of apoptosis, autophagy and/or cell cycle
arrest. Hep3B and A549 cells treated with various concentrations of
Rhabdastrellic acid-A for 48 h and analyzed for the cell cycle by
flow cytometry. Fig. 2B showed that Rhabdastrellic acid-A did not
induce cell cycle arrest in Hep3B and A549 cells within these
concentration ranges at 48 h. Thereby, we investigated whether
Rhabdastrellic acid-A could induce apoptosis or autophagy-
associated cell death in Hep3B and A549 cells.
Many kinds of anticancer agents function to induce apoptosis of
cancer cells which is characterized by caspase-3 and PARP
cleavage. To determine whether the cell death was caspase-
dependent, we first detected the cleavage of caspase-3. Using
immunoblotting analysis, the cleavage of caspase-3 in both cancer
cells was not observed following treatment with Rhabdastrellic
acid-A. The cleavage of PARP was also undetectable (Fig. 2A).
The cleavage of caspase-3 and PARP was also detected in both cell
lines treated with adriamycin. The results showed that pro-
caspase-3 was cleaved to yield a 17 KDa fragmentation and PARP
was cleaved into 89 KDa fragmentation following adriamycin
treatment (Fig. 3A). Furthermore, the pan-caspase inhibitor, z-
VAD-fmk, did not inhibit Rhabdastrellic acid-A induced cell death
(Fig. 3B). To further confirm that Rhabdastrellic acid-A mainly
induced non-apoptotic cell death, Hep3B and A549 cells exposed
to various concentrations of Rhabdastrellic acid-A were analyzed
at 48 h intervals by Annexin V-FITC/PI staining assay. As shown
in Fig. 3C, the highest apoptotic rates were 4.4% in Hep3B cells
and 0.2% in A549 cells after treatment. These results strongly
indicated that Rhabdastrellic acid-A induced a caspase-indepen-
dent cell death in Hep3B and A549 cells.
2. Autophagy-associated cell death induced by
Rhabdastrellic acid-A in cancer cells
Rhabdastrellic acid-A induces the formation of autoph-
agosomes. The membrane-associated light chain 3 protein,
MAP LC3 (Atg8), localizes to the elongation membrane and stays
in the membrane until autophagosome maturation. It is a key
marker for autophagy. Upon induction of autophagy, LC3-I is
Figure 1. Molecular structure of Rhabdastrellic acid-A.
doi:10.1371/journal.pone.0012176.g001
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phosphatidylethanolamine (PE) and tightly bound to the
autophagosomal membranes forming ring-shaped structures in
the cytoplasm. To measure autophagy, Hep3B and A549 cells
were transfected with an expression construct for LC3 fused to
yellow fluorescent protein (YFP-LC3). In DMSO-treated control
cells YFP-LC3 was evenly distributed in the entire cytoplasm.
After Rhabdastrellic acid-A treatment, ring-shaped structures were
detectable in the cytosol, indicating the association of YFP-LC3
with autophagosomal membranes following an induction of
autophagy (Fig 4A). Ultrastructural analysis of Rhabdastrellic
acid-A-treated A549 cells by electron microscopy showed large
autophagic vacuoles in contrast to control cells where no such
vacuoles could be detected (Fig. 4B).
LC3-II expression induced by Rhabdastrellic acid-A in
cancer cells. The amount of PE-conjugated form of LC3 (LC3-
II) correlates well with the number of autophagosomes. After
Rhabdastrellic acid-A treatment for the indicated times, LC3 was
detected by immunoblotting analysis. The results indicated that
the expression of LC3-II was gradually upregulated (Fig 4C). This
confirmed the results of YFP-LC3 transfection and indicated that
Rhabdastrellic acid-A could induce autophagy in Hep3B and
A549 cells.
Autophagy-associated cell death induced by Rhabda-
strellic acid-A in cancer cells. To confirm that
Rhabdastrellic acid-A induced autophagy-associated cell death,
Hep3B cells were treated with Rhabdastrellic acid-A and/or 3-
methyladenine (an inhibitor of PI3K-C3 commonly used for
specific inhibition of autophagy). In contrast to control cells, after
Rhabdastrellic acid-A treatment, most of the Hep3B cells
appeared round, some were detached from the surface of wells
and the number of cells was reduced (Fig 5A). However, the effects
by Rhabdastrellic acid-A treatment were reversed by 3-MA
(Fig 5A). It was suggested that the induction of cell death by
Rhabdastrellic acid-A treatment was blocked when the cells were
in parallel treated with autophagy inhibitor 3-MA.
shRNA-based depletion of an essential autophagy protein Atg5,
effectively blocked Rhabdastrellic acid-A-induced LC3-II accu-
mulation (Fig 5B). And the inhibition of autophagy by depletion of
Atg5 inhibited Rhabdastrellic acid-A-induced cell death in A549
cells within the concentration ranges from 0.05 to 3.2 mg/mL
(Fig 5C).
A549 cells exposed to 4 mM Rhabdastrellic acid-A and/or 3-
MA were analyzed for cell death at 24 h by flow cytometry.
Propidium iodide (PI) positive were counted as ‘dead’ cells. The
cell death induced by Rhabdastrellic acid-A was suppressed when
the cells were treated in combination with 3-MA (Fig. 5D).
3. Rhabdastrellic acid-A inhibited Akt pathway in Hep3B
and A549 cells
Rhabdastrellic acid-A could inhibit Akt pathway in HL-60
cells[4]. Therefore, it was interesting to test whether it was the
Figure 2. Growth inhibition of Rhabdastrellic acid-A on Hep3B and A549 cells. A. Cancer cells were plated at the density of 8000 cells/well
in a 96-well plate. The stock of Rhabdastrellic acid-A was added to wells. Cells were cultured for 3 days. MTT assay was conducted. B. Hep3B and A549
cells were treated with indicated concentrations of Rhabdastrellic acid-A for 48 h and analyzed for the DNA content by flow cytometry. The results
were representative of 3 experiments.
doi:10.1371/journal.pone.0012176.g002
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PLoS ONE | www.plosone.org 3 August 2010 | Volume 5 | Issue 8 | e12176Figure 3. Rhabdastrellic acid-A induced caspase-independent cell death in Hep3B and A549 cells. A. in Hep3B and A549 cells, Cell lysates were
prepared from 0.1% DMSO, 1 mg/mL Rhabdastrellic acid-A or 4 mM adriamycin for 24 h and 48 h. Western blot analysis was conducted with caspase-3 and
P A R Pa n t i b o d i e s .B .C e l l sw e r ei n c u b a t e dw ith various concentrations of Rhabdastrellic acid-A in the presence or absence of 20 mM z-VAD-fmk for 3 d. MTT
assay was conducted. Results (mean6S.E.) represent the average of three experiments. C. Hep3B and A549 cells were treated with 0 to 4 mg/mL Rhabdastrellic
acid-A for 48 h. After treatment, the cells were collected sequentially and stained with Annexin V and PI and analysed by the flow cytometry assay.
doi:10.1371/journal.pone.0012176.g003
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Rhabdastrellic acid-A treatment for the indicated times or various
concentrations, Rhabdastrellic acid-A inhibited the phosphoryla-
tion of Akt in Hep3B and A549 cells.
mTOR, FKHR and STAT3 are three important downstream
targets of Akt pathway and play key roles in autophagy and
apoptosis[33]. As shown in the results (Fig 6B), the phosphoryla-
tion of mTOR, FKHR and STAT3 had dramatic decrease after
Rhabdastrellic acid-A treatment in a time-dependent manner in
both cell lines. These results indicated that AKT pathway was
inhibited by Rhabdastrellic aicd-A in Hep3B and A549 cells.
4. The induction of autophagy by Rhabdastrellic acid-A
was abrogated by constitutive active Akt ectopic
expression
Rhabdastrellic acid-A could inhibit Akt pathway and induce
autophagy in Hep3B cells. In order to further confirm an intrinsic
role of Akt in autophagy induced by Rhabdastrellic acid-A, we
transfected the Hep3B cells with myr-Akt1 plasmids (activated) and
selected the positive clone using G418. Compared with the control
cells (Hep3B cells transfected with the vector plasmid), the
exogenous Akt expression significantly increased in Hep3B/myr-
Akt1 cells (Fig. 7A). Furthermore, the marker of autophagy was
determined while constitutive active Akt expression in Hep3B cells.
Compared with the control cells, massive induction of autophagy
was observed in Hep3B cells, indicated by increase of LC3-II.
However, expressing constitutive active Akt blocked increase of
LC3-II (Fig 7B). Consistent with the notion that some population of
LC3-II is degraded in lysosomes [34], treatment with lysosomal
enzyme inhibitors Pepstatin A resulted in the accumulation of LC3-
II in cancer cells (Fig 7C), this phenomenon was also impaired while
constitutive active Akt ectopic expression. Furthermore, constitutive
active Akt expression could rescue Hep3B cells from Rhabdasterllic
acid-A-mediated growth inhibition under treatment of Rhabdas-
trellic acid-A (Fig. 7D). These results shown in Fig 7 indicated that
constitutive active Akt expression could inhibit Rhabdastrellic acid-
A-mediated autophagy.
To investigate whether other pathways are involved in
autophagy induced by Rhabdastrellic acid-A, we analysed the
levels of Bip, CHOP, phospho-EIF2a and phospho-AMPK in
Hep3B cells following Rhabdastrellic acid-A treatment. The
results showed that phosphorylation of AMPK, EIF2a and CHOP
increased after Rhabdastrellic acid-A treatment in a dose-
dependent manner in Hep3B cells. However, an increase of Bip
was not detected (shown in Fig. S1). These results indicated that
multiple pathways might be involved in Rhabdastrellic acid-A-
induced autophagy.
Discussion
The results described here demonstrate that Rhabdastrellic
acid-A could induce autophagy in the human cancer cell lines.
Figure 4. Rhabdastrellic acid-A induced autophagy in Hep3B and A549 cells. A. Hep3B and A549 cells were transfected with an expression
construct for LC3 fused to yellow fluorescent protein (YFP-LC3) for 24 h. Thereafter, cells were treated with or without 1 mg/mL or 4 mg/mL
Rhabdastrellic acid-A for 36 h, and visualized under a confocal microscope. B. Electron micrograph showing autophagic vacuole of A549 cells
following 4 mg/mL Rhabdastrellic acid-A treatment. C. Rhabdastrellic acid-A time-dependently induced the formation of LC3-II, a marker for
autophagy. Hep3B and A549 cells were treated with 1 mg/mL Rhabdastrellic acid-A for the indicated times. Lysates were analyzed by immunoblotting
with LC3 antibody.
doi:10.1371/journal.pone.0012176.g004
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A549 cells, and constitutive active Akt expression could inhibit
Rhabdastrellic acid-A-mediated autophagy. These results indicat-
ed that inhibition of Akt/mTOR pathway is involved in
Rhabdastrellic acid-A induced autophagy and cell death.
Autophagy has been reported to be a process whereby double
membrane vacuoles termed autophagosomes form around, engulf,
cytosol and organelles. Though autophagy was reported to effect
as a prosurvival response, in some instance, the cytotoxicity of
arsenic trioxide, imatinib, ionizing radiation etc. to some cell types
is mediated by the induction of autophagy. In those circumstances,
autophagy constitutes a nonapoptotic pathway for programmed
cell death. Many reports show that triterpenoids have potential
cytotoxicity to cancer cell lines [35,36]. Rhabdastrellic acid-A is
one of the triterpenoids that induced non-apoptotic cell death in
Hep3B and A549 cells. Therefore, we explored whether the
induction of autophagy was required for Rhabdastrellic acid-A -
mediated cell death in these two cancer cell lines. Autophagic cells
enlarge without permeabilization of the plasma membrane,
convert LC3-I to LC-II, show punctate cytoplasmic LC3
translocation and develop autophagosome. In this study, Hep3B
and A549 cells exhibited morphologic and biochemical features
that are characteristic of cells undergoing autophagy, not apoptosis
following Rhadastrellic acid-A treatment. Also, growth inhibition
of Rhabdasterllic acid-A in A549 cells was weaker than that in
Hep3B cells. But Rhabdasterllic acid-A increased more LC3-II
expression. Conversion of LC3-I to LC3-II can be observed in
autophagy initiation. But partial LC3-II can be degraded when
autophagy maturation. Only LC3-II expression could not indicate
the sensitivity to autophagy.
Previous studies on mechanism underlying the regulation of
autophagy in cancer cells showed that autophagy was regulated by
multiple signaling pathways as diverse as the class III PI 3-kinase,
and the protein kinases mTOR, ERK, and p38. Aberrant
activation of Akt/mTOR signaling pathway was implicated in a
variety of human malignances [20,21,22,23,24,25,37]. Phosphor-
Figure 5. Requirement of autophagy induction for Rhabdastrellic acid-A-induced cell death. A. Hep3B cells were treated with 1 mg/mL
Rhabdastrellic acid-A and/or 10 mM 3-MA for 36 h, and then examined by inverted microscope. *, p,0.05 vs. Rhabdastrellic acid-A2/3-MA-.
**, p,0.05 vs. Rhabdastrellic acid-A+/3-MA-. B. Lysates from A549-Vector and A549-shAtg5 cells were analyzed by immunoblotting with Atg5 and LC3
antibodies. C. A549 vector cells and A549-shAtg5 cells were cultured at 6000 cells per well in a 96-well plate, exposed to different concentrations of
Rhabdastrellic acid-A from 0.05 to 3.2 mg/mL for 72 h. The growth inhibition was detected using MTT assay. Reported values are mean 6 SD of
triplicate samples from a representative experiment. *P-vlaue,0.05 as compared with cells treated in the same way, but transfected without shRNA.
D. A549 Cells were incubated with 4 mg/mL Rhabdastrellic acid-A and/or 10 mM 3-MA for 24 h. Cell death was quantified using flow cytometry as PI
staining assay. The experiment was repeated 3 times.
doi:10.1371/journal.pone.0012176.g005
Autophagy Induced by Rh Acid-A
PLoS ONE | www.plosone.org 6 August 2010 | Volume 5 | Issue 8 | e12176ylated Akt plays central roles in some fundamental processes,
including cell proliferation, cell death, cell motility/adhesion, cell
transformation, and neovascularization. When activated, Akt acts
as a survival factor by preventing release of cytochrome c from
mitochondria and inactivating FKHR which is known to induce
expression of pro-apoptotic factors such as Fas ligand [38].
Inhibition of mTOR induces apoptosis in some types of tumor
cells, whereas they trigger autophagy in other settings. Rapamycin,
an inhibitor of mTOR, was reported to induce the classic
autophagic cell death in cancer cells. Our previous study also
showed that Rhabdastrellic acid-A inhibited PI3K/Akt pathway
and induced apoptosis in human leukemia HL-60 cells[4]. So
inhibition of Akt may activate some autophagy-related proteins
and induce autophagy. In keeping with this finding, we observed
that Rhabdastrellic acid-A could inhibit the phosphorylation of
Akt in Hep3B and A549 cells. The phosphorylation of mTOR,
FKHR and STAT3 also dramatically decreased after Rhabdas-
trellic acid-A treatment. Furthermore, ectopic constitutive active
Akt expression could block autophagy induced by Rhadastrellic
acid-A. Taken together, Rhadastrellic acid-A induced autophagy
through inhibition of Akt/mTOR pathway.
In summary, the current studies show that Rhabdastrellic acid-A
kills Hep3B and A549 cells via the induction of autophagy. Inhibition
of the Akt/mTOR pathway plays a key role in Rhabdastrellic acid-A-
mediated autophagy. As tumor cells frequently acquire defects in
autophagy compared with normal cells, pharmacological activation
of autophagy through inhibition of Akt/mTOR pathway may kill
cancer cells and limit tumorigenesis, especially in cancers with defects
in apoptosis. Our study alsoprovides the evidence that Rhabdastrellic
acid-A deserves further investigation as a potential anticancer agent
or cancer preventive agent.
Materials and Methods
Drugs and reagents
Rhabdastrellic acid-A was isolated from the sponge Rhabdas-
trella globostellata and initially dissolved in 100% Dimethylsul-
foxid (DMSO) and stored at 220uC. Methylthiazolyldiphenyl-
tetrazolium bromide (MTT) and 3-methyladenine (3-MA) were
purchased from Sigma Co. (Sigma Aldrich, M2128). RPMI
medium 1640 were purchased from invitrogen (Invitrogen,
11875).
Figure 6. The effect of Rhabdastrellic acid-A on Akt pathway in Hep3B and A549 cells. Hep3B and A549 cells were treated with
Rhabdastrellic acid-A in the indicated concentrations for 36 h or treated with 1 mg/mL or 4 mg/mL Rhabdastrellic acid-A for the indicated times. A.
Cells were sequentially harvested and lysed. cell lysates were analyzed by immunoblotting with phospho-Akt or Akt antibodies. B. mTOR, phospho-
mTOR, FKHR, phospho-FKHR, STAT3 and phospho-STAT3 were analyzed by immunoblotting. The experiment was performed 3 times.
doi:10.1371/journal.pone.0012176.g006
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Human hepatocellular carcinoma cell line Hep3B[39] and
human lung adenocarcinoma epithelial cell line A549[40] were
cultured in RPMI-1640 supplemented with 10% heat-inactivated
fetal bovine serum, penicillin (50U/mL), and streptomycin (50 mg/
mL). The cells were incubated at 37uC in humidified 5% CO2.
MTT assay
Cells were plated in 96-well plate. The stock of Rhabdastrellic
acid-A was diluted, added to the wells for the desired final assay
concentration. After 3 days exposure to Rhabdastrellic acid-A,
10 mL of MTT (5 mg/L) was added to each well and incubated for
four more hours, then liquid in the wells was evaporated. 100 mL
of DMSO was added to each well. The absorbance was detected
in the microplate reader 550 model with 565 nm wave length (Bio-
rad Co., 17024). Growth inhibition was calculated and IC50 value
was determined using the Bliss Software.
Annexin V-FITC/PI staining assay
Cells with different treatments were collected, resuspended with
10% 1640 medium, adjusted the cell suspension concentration to
approximately 1610
6 cells/ml, and transferred 0.5 ml of cell
suspension to a microfuge tube. After added 10 ml media binding
reagent and 1.25 ml Annexin V-FITC, cells were incubated at
room temperature for 15 min in the dark, then centrifuged and
removed media. When resuspended in 0.5 ml cold 16binding
Buffer (10 mM HEPES, 150 mM NaCl, 2.5 mM CaCl2, 1 mM
MgCl2, 20% BSA pH 7.4), cells were added 10 ml propidium
iodide (30 mg/ml), placing samples on ice and away from light.
Apoptosis was analysed by flow cytometry ((Beckman Coulter,
Fullerton, CA) at the wavelength of 488 nm immediately.
Cell cycle detection
Cells were collected, resuspended with 1 ml precooled 70% ethanol,
and fixed in 4uC overnight. After removed ethanol and added 0.5 ml
staining solution (50 mg/ml PI, 100 mg/ml RNaseA, 0.2% Triton-
100), cells were incubated in 37uC for 30 min in the dark. Cell cycle
distribution was analysed by flow cytometry ((Beckman Coulter,
Fullerton, CA) at the wavelength of 488 nm immediately.
PI staining assay
Cells were trypsinized with 0.5 ml 0.25% trypsin for 3 min, collected
and resuspended with 1 ml precooled PBS. After added 0.5 ml staining
solution (50 mg/ml PI, 100 mg/ml RNaseA, 0.2% Triton-100), cells
were incubated in 37uC for 30 min in the dark. Cell death was detected
by flow cytometry ((Beckman Coulter, Fullerton, CA).
Confocal microscopy and indirect immunofluorescence
Cells were grown on glass coverslips and transfected with pYFP-
LC3 for Hep3B and A549 cells. 36 h after transfection the cells
Figure 7. Constitutive active Akt expression could inhibit Rhabdastrellic acid-A-mediated autophagy. A. A. the positive clone stably
expressed myr-Akt1 was analyzed by immunoblotting with Akt antibody. B. Hep3B cells were treated with 1 mg/mL Rhabdastrellic acid-A for 36 h in
the absence or presence of constitutive active Akt ectopic expression. Then LC3 protein expression was analyzed. C. Cancer cells were treated with
1 mg/mL Rhabdastrellic acid-A and/or 10 mg/mL pepstatin A (pepA) for 36 h, Then LC3 protein expression was analyzed. D. After treatment, viable
cells of two cell lines were measured. *, p,0.05 vs. Rhabdastrellic acid-A (vector).
doi:10.1371/journal.pone.0012176.g007
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additional 36 h. Cells were fixed with 4% paraformaldehyde in
PBS for 30 min at room temperature, the slides were mounted in
anti-fading solution and stored at 4uC. The coverslips were viewed
with an laser-scanning confocal microscope (Olympus, FV-1000).
Electron microscopy
Cells were fixed by immersion in a mixture of 2.5%
glutaraldehyde, 2.5% paraformaldehyde and 0.05% picric acid
in 0.067M cacodylate buffer (pH 7.4). Postfixation was performed
in 1% osmium tetroxide followed by an overnight immersion with
0.3% uranylacetate dissolved in 50 mM maleate buffer (pH 5.0).
Standard procedures for dehydration and embedding in Epon
were employed. Thin sections were further stained with lead
citrate, and were examined in an electron microscope (Philip,
CN10).
Western blot analysis
Lysates were prepared from 4610
5 cells by dissolving cell pellets
in 100 mL of lysis buffer (20 mM Na2PO4 (pH 7.4), 150 mM
NaCl, 1% Triton X-100, 1% aprotinin, 1 mM phenymethysulfo-
nyl fluoride, 10 mg/mL leupeptin, 100 mM NaF, and 2 mM
Na3VO4). Lysates were centrifuged at 12,000 rpm for 10 min. The
supernatant was collected. The protein content was determined
using the Bio-Rad protein assay. SDS-PAGE sample buffer
(10 mM Tris-HCl, pH 6.8, 2% SDS, 10% Glycerol, 0.2 M
DTT) was added to lysates. Lysates were heated to 100uC for
5 min, and 40 mg of protein was loaded in each well of a 4–20%
SDS-PAGE gel. Resolved proteins were electrophoretically
transferred to nitrocellulose and incubated sequentially with
primary antibody and horseradish peroxidase-conjugated goat
anti-mouse IgG (Santa Cruz, sc-2005) or goat anti-rabbit-IgG
(Santa Cruz, sc-2004). After washing, the bound antibody complex
was detected using LumiGLO reagent (Cell Signaling Technology,
#7003) and XAR film (Kodak, XBT-1) as described by the
manufactures. The following primary antibodies were used:
caspase-3 antibody (Santa Cruz, sc-7272), PARP antibody (Santa
Cruz, sc-7150), glyceraldehyde 3-phosphate dehydrogenase anti-
body (Santa Cruz, sc-47724), LC3 antibody (Novus Biologicals,
NB100-2220), Atg5 antibody (Cell Signaling Technology, #2630),
Phospho-Akt1/2/3(ser473) antibody (Santa Cruz, sc-7985-R),
Akt1 antibody (Santa Cruz, sc-1618), Phospho-mTOR(ser2448)
antibody(Cell Signaling Technology, #2971), mTOR antibody
(Cell Signaling Technology, #2972), Phospho-FKHR(ser256)
antibody (Cell Signaling Technology, #9461), FKHR antibody
(Cell Signaling Technology, #9462), Phospho-STAT3(ser727)
antibody (Santa Cruz, sc-8001-R), STAT3 antibody (Cell
Signaling Technology, #9132).
Plasmids and transfection
myr-Akt1 (activated #21–151) or empty plasmid (pUSEamp(+)
#21–147) were purchased from upstate Co. Hep3B cells were
seeded into 6-well plate the day before transfection. Transfections
of myr-Akt1 (activated) or empty plasmid (vector) were performed
with Lipofectamine 2000 (Invitrogen, 11668019) according to the
protocol suggested by the manufacture. After 48 h of transfection,
the positive clones were selected under G418 (1000 mg/mL).
Constructs, Retroviral Infection, and RNA interference
For stable ATG5 siRNA expression, the retroviral vector
(pSUPER. puro, a gift of Professor Musheng Zeng, Cancer
Center, Sun Yat-sen University, Guangzhou, China) encoding
hairpin RNA sequences was constructed. A distinct short hairpin
RN (shRNA) sequences against ATG5 (shATG5) were generated
and cloned into the expression vector. The ATG5 sense primers
were: 59-GGC ATT ATC CAA TTG GTT TA-39, Vesicular
stomatitis virus–pseudotyped vectors were produced by transfec-
tion of the VSV-GPG producer cell line with 5 mg DNA using
lipofectamine 2000 (Invitrogen) in a six-well plate. Retrovirus-
containing supernatants were collected at days 5 to 7 after
transfection. Then A549 cells were infected with retrovirus-
containing supernatants thrice. The positive cells stably expressing
shATG5 were selected under puromycine (1 mg/mL).
Supporting Information
Figure S1 Rhadbstrellic acid-A up-regulated p-AMPK, p-EIF2a,
CHOP proteins in Hep3B cells. Hep3B cells were treated with 0–
2 mg/mL Rhadbstrellic acid-A for 36 h, then the cells were
collected and lysed. Cell lysates were analyzed by immunoblotting
with phospho-AMPK, phospho-EIF2a, Bip and CHOP antibodies.
Found at: doi:10.1371/journal.pone.0012176.s001 (2.04 MB
TIF)
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